Valuation: IOL Chemicals and Pharmaceuticals Limited

Market Cap 50.22B 527M 461M 425M 392M 745M 757M 5.08B 1.99B 24.74B 1.98B 1.93B 85.06B P/E 2026
15.5x
P/E 2027 * -
Enterprise Value 50.22B 527M 461M 425M 392M 745M 757M 5.08B 1.99B 24.74B 1.98B 1.93B 85.06B EV / Sales 2026
0.92x
EV / Sales 2027 * 1.9x
Free-Float
33.91%
Yield 2026 *
-
Yield 2027 * -
1 day+1.73%
1 week+19.66%
Current month+17.74%
1 month+33.81%
3 months+108.30%
6 months+118.33%
Current year+107.95%
1 week 143
Extreme 143
177.9
1 month 123.2
Extreme 123.2
177.9
Current year 67.19
Extreme 67.19
177.9
1 year 67.19
Extreme 67.19
177.9
3 years 57.5
Extreme 57.5
177.9
5 years 54.56
Extreme 54.56
177.9
10 years 9.2
Extreme 9.2
179.78
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 2019-11-13
Director TitleAgeSince
Chairman 63 2007-08-31
Director/Board Member 34 2015-05-28
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+19.66% - - 527M
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -0.88%-3.25%+26.72%+56.70% 397.1B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.91%

Financials

2026 2027 *
Net sales 23.04B 242M 211M 195M 180M 341M 347M 2.33B 914M 11.35B 907M 887M 39.01B 26.48B 278M 243M 224M 207M 393M 399M 2.68B 1.05B 13.05B 1.04B 1.02B 44.85B
Net income 1.3B 13.59M 11.89M 10.96M 10.13M 19.21M 19.54M 131M 51.44M 638M 51.02M 49.91M 2.19B -
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
2,891
Date Price Change Volume
26-07-10 ₹171.06 +1.73% 4,120,062
26-07-09 ₹168.15 +0.62% 8,148,178
26-07-08 ₹167.11 +1.25% 33,183,238
26-07-07 ₹165.04 +14.25% 41,176,929
26-07-06 ₹144.46 +1.05% 2,557,694
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
171.10INR
Average target price
150.00INR
Spread / Average Target
-12.33%

Quarterly revenue - Rate of surprise